Core Insights - The article presents new data from a proof-of-concept study on the detection of circulating tumor cells (CTCs) in glioblastoma patients, highlighting the effectiveness of the Parsortix label-free methodology [1] Company Overview - ANGLE plc is a leading company in the liquid biopsy sector, specializing in innovative CTC solutions for research, drug development, and clinical oncology [1] Study Details - The study involved 15 newly diagnosed, treatment-naïve glioblastoma (GBM) patients, with blood samples processed using the Parsortix® system and CellKeep™ slides [1]

S-1 1 bion_s1.htm FORM S-1 As filed with the Securities and Exchange Commission on February 14, 2023 Registration No. 333-[●] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BIONEXUS GENE LAB CORP. Wyoming 8071 35-2604830 (I.R.S. Employer (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Identification Number) Unit 02, Level 10, Tower B, Vertical Busi ...